{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:23:28Z","timestamp":1791944608477,"version":"4.3.4"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12022-017-9498-z","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T04:56:02Z","timestamp":1501563362000},"page":"228-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":391,"title":["Overview of the 2017 WHO Classification of Pituitary Tumors"],"prefix":"10.1007","volume":"28","author":[{"given":"Ozgur","family":"Mete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Beatriz","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"9498_CR1","volume-title":"WHO Classification of Tumours of the Central Nervous System","year":"2016","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenne C (Eds). WHO Classification of Tumours of the Central Nervous System. Revised 4th Edition. IARC: Lyon, 2016.","edition":"Revised 4th"},{"issue":"5","key":"9498_CR2","first-page":"1275","volume":"77","author":"SL Asa","year":"1993","unstructured":"Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77(5):1275\u20131280, 1993.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9498_CR3","first-page":"1281","volume":"77","author":"KE Friend","year":"1993","unstructured":"Friend KE, Chiou YK, Laws ER Jr, Lopes MB, Shupnik MA. Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 77(5):1281\u20131286, 1993.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9498_CR4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1097-0029(19971015)39:2<168::AID-JEMT8>3.0.CO;2-H","volume":"39","author":"RV Lloyd","year":"1997","unstructured":"Lloyd RV, Osamura RY. Transcription factors in normal and neoplastic pituitary tissues. Microsc Res Tech 39(2):168\u2013181, 1997.","journal-title":"Microsc Res Tech"},{"issue":"4","key":"9498_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1507\/endocrj.K10E-389","volume":"58","author":"Y Tani","year":"2011","unstructured":"Tani Y, Sugiyama T, Izumiyama H, Yoshimoto T, Yamada S, Hirata Y. Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors. Endocr J 58(4):297\u2013303, 2011.","journal-title":"Endocr J"},{"issue":"6","key":"9498_CR6","first-page":"2165","volume":"81","author":"SL Asa","year":"1996","unstructured":"Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 81(6):2165\u20132170, 1996.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9498_CR7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O, et al. The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26(4):349\u2013355, 2015.","journal-title":"Endocr Pathol"},{"key":"9498_CR8","first-page":"9","volume-title":"World Health Organization Classification of Tumours: pathology and genetics of tumours of endocrine organs","year":"2004","unstructured":"De Lellis RA, Lloyd RV, Heitz PU et al. (eds) World Health Organization Classification of Tumours: pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, p 9\u201347, 2004."},{"issue":"2","key":"9498_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3171\/2010.8.JNS10290","volume":"114","author":"G Zada","year":"2011","unstructured":"Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr. Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114(2):336\u2013344, 2011.","journal-title":"J Neurosurg"},{"key":"9498_CR10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jocn.2016.09.014","volume":"34","author":"HA Zaidi","year":"2016","unstructured":"Zaidi HA, Cote DJ, Dunn IF, Laws ER Jr. Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas. J Clin Neurosci 34:246\u2013251, 2016.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"9498_CR11","first-page":"226","volume":"23","author":"AE Yildirim","year":"2013","unstructured":"Yildirim AE, Divanlioglu D, Nacar OA, Dursun E, Sahinoglu M, Unal T, Belen AD. Incidence, hormonal distribution and postoperative follow up of atypical pituitary adenomas. Turk Neurosurg 23(2):226\u2013231, 2013.","journal-title":"Turk Neurosurg"},{"issue":"2","key":"9498_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000375448","volume":"101","author":"S Chiloiro","year":"2015","unstructured":"Chiloiro S, Doglietto F, Trapasso B, et al. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis. Neuroendocrinology 101(2):143\u2013150, 2015.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"9498_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10143-016-0740-9","volume":"40","author":"M Basso De Caro Del","year":"2017","unstructured":"Del Basso De Caro M, Solari D, Pagliuca F, et al. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurg Rev 40(1):105\u2013114, 2017.","journal-title":"Neurosurg Rev"},{"key":"9498_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40478-015-0229-8","volume":"3","author":"CP Miermeister","year":"2015","unstructured":"Miermeister CP, Petersenn S, Buchfelder M, et al. Histological criteria for atypical pituitary adenomas\u2014data from the German pituitary adenoma registry suggests modifications. Acta Neuropathol Commun 3:50, 2015.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"9498_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000371806","volume":"101","author":"E Chatzellis","year":"2015","unstructured":"Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G. Aggressive pituitary tumors. Neuroendocrinology 101(2):87\u2013104, 2015.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"9498_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2014.10.001","volume":"44","author":"G Raverot","year":"2015","unstructured":"Raverot G, Vasiljevic A, Jouanneau E, Trouillas J. A prognostic clinicopathologic classification of pituitary endocrine tumors. Endocrinol Metab Clin N Am 44(1):11\u201318, 2015.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"9498_CR17","first-page":"377","volume":"41","author":"A Vasiljevic","year":"2016","unstructured":"Vasiljevic A, Jouanneau E, Trouillas J, Raverot G. Clinicopathological prognostic and theranostic markers in pituitary tumors. Minerva Endocrinol 41(3):377\u2013389, 2016.","journal-title":"Minerva Endocrinol"},{"issue":"2","key":"9498_CR18","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JME-12-0113","volume":"49","author":"O Mete","year":"2012","unstructured":"Mete O, Ezzat S, Asa SL. Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 49(2):R69\u2013R78, 2012.","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"9498_CR19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11102-014-0578-5","volume":"18","author":"CC Lee","year":"2015","unstructured":"Lee CC, Vance ML, Lopes MB, Xu Z, Chen CJ, Sheehan J. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype. Pituitary 18(3):326\u2013334, 2015.","journal-title":"Pituitary"},{"issue":"2","key":"9498_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2015.151","volume":"29","author":"O Mete","year":"2016","unstructured":"Mete O, Gomez-Hernandez K, Kucharczyk W, et al. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Mod Pathol 29(2):131\u2013142, 2016.","journal-title":"Mod Pathol"},{"issue":"4","key":"9498_CR21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijrobp.2014.07.013","volume":"90","author":"Z Xu","year":"2014","unstructured":"Xu Z, Ellis S, Lee CC, Starke RM, et al. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study. Int J Radiat Oncol Biol Phys 90(4):903\u2013910, 2014.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"9498_CR22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","volume":"154","author":"H Alahmadi","year":"2012","unstructured":"Alahmadi H, Lee D, Wilson JR, et al. Clinical features of silent corticotroph adenomas. Acta Neurochir (Wien). 154(8):1493\u20131498, 2012.","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"9498_CR23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-008-0388-9","volume":"116","author":"BW Scheithauer","year":"2008","unstructured":"Scheithauer BW, Kovacs K, Horvath E, et al. Pituitary blastoma. Acta Neuropathol 116 (6):657\u2013666, 2008.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"9498_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11102-011-0328-x","volume":"15","author":"BW Scheithauer","year":"2012","unstructured":"Scheithauer BW, Horvath E, Abel TW, et al. Pituitary blastoma: a unique embryonal tumor. Pituitary 15(3):365\u2013373, 2012.","journal-title":"Pituitary"},{"issue":"8","key":"9498_CR25","doi-asserted-by":"crossref","first-page":"E1487","DOI":"10.1210\/jc.2014-1016","volume":"99","author":"T Sahakitrungruang","year":"2014","unstructured":"Sahakitrungruang T, Srichomthong C, Pornkunwilai S, et al.. Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing\u2019s disease. J Clin Endocrinol Metab 99(8):E1487\u2013E1492, 2014.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9498_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","volume":"128","author":"L Kock de","year":"2014","unstructured":"de Kock L, Sabbaghian N, Plourde F, et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol 128(1):111\u2013122, 2014.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"9498_CR27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/br.2015.430","volume":"3","author":"P Peng","year":"2015","unstructured":"Peng P, Chen F, Zhou D, Liu H, Li J. Neurocytoma of the pituitary gland: A case report and literature review. Biomed Rep 3(3):301\u2013303, 2015.","journal-title":"Biomed Rep"},{"issue":"12","key":"9498_CR28","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00701-006-0895-1","volume":"148","author":"N Boari","year":"2016","unstructured":"Boari N, Losa M, Mortini P, Snider S, Terreni MR, Giovanelli M. Intrasellar paraganglioma: a case report and review of the literature. Acta Neurochir (Wien). 148(12):1311\u20131314; discussion 1314, 2016.","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"9498_CR29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ando.2012.02.001","volume":"73","author":"M Dupuy","year":"2012","unstructured":"Dupuy M, Bonneville F, Grunenwald S, et al. Primary sellar neuroblastoma. A new case and review of literature. Ann Endocrinol (Paris). 73(3):216\u2013221, 2012.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"9498_CR30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO;2-3","volume":"79","author":"PJ Pernicone","year":"1997","unstructured":"Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79(4):804\u2013812, 1997.","journal-title":"Cancer"},{"issue":"4","key":"9498_CR31","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/foc.2004.16.4.8","volume":"16","author":"BT Ragel","year":"2004","unstructured":"Ragel BT, Couldwell WT. Pituitary carcinoma: a review of the literature. Neurosurg Focus 16(4):E7, 2004.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"9498_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/ENDO:28:1:115","volume":"28","author":"MB Lopes","year":"2005","unstructured":"Lopes MB, Scheithauer BW, Schiff D. Pituitary carcinoma: diagnosis and treatment. Endocrine 28(1):115\u2013121, 2005.","journal-title":"Endocrine"},{"key":"9498_CR33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000318499","volume":"38","author":"A Colao","year":"2010","unstructured":"Colao A, Ochoa AS, Auriemma RS, Faggiano A, Pivonello R, Lombardi G. Pituitary carcinomas. Front Horm Res38:94\u2013108, 2010.","journal-title":"Front Horm Res"},{"issue":"4","key":"9498_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","volume":"22","author":"O Mete","year":"2012","unstructured":"Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain Pathol 22(4):443\u2013453, 2012.","journal-title":"Brain Pathol"},{"issue":"4","key":"9498_CR35","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24(4):C5-C8, 2017.","journal-title":"Endocr Relat Cancer"},{"key":"9498_CR36","volume-title":"Tumors of the Pituitary Gland. AFIP Atlas of Tumor Pathology, Series 4, Fascicle 15","author":"SL Asa","year":"2011","unstructured":"Asa SL. Tumors of the Pituitary Gland. AFIP Atlas of Tumor Pathology, Series 4, Fascicle 15. Silver Spring, ARP Press. 2011."},{"issue":"Suppl 1","key":"9498_CR37","first-page":"4","volume":"31","author":"K Gomez-Hernandez","year":"2015","unstructured":"Gomez-Hernandez K, Ezzat S, Asa SL, Mete \u00d6. Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician. Turk Patoloji Derg 31 Suppl 1:4\u201317, 2015.","journal-title":"Turk Patoloji Derg"},{"issue":"3","key":"9498_CR38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.semdp.2013.06.002","volume":"30","author":"O Mete","year":"2013","unstructured":"Mete O, Asa SL. Therapeutic implications of accurate classification of pituitary adenomas. Semin Diagn Pathol 30(3):158\u2013164, 2013.","journal-title":"Semin Diagn Pathol"},{"key":"9498_CR39","doi-asserted-by":"crossref","unstructured":"Asa SL, Mete O. What\u2019s new in pituitary pathology. Histopathology, 2017. In press.","DOI":"10.1111\/his.13295"},{"issue":"5","key":"9498_CR40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/cen.12207","volume":"79","author":"TA Howlett","year":"2013","unstructured":"Howlett TA, Willis D, Walker G, Wass JA, Trainer PJ; UK Acromegaly Register Study Group (UKAR-3). Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists. Clin Endocrinol (Oxf). 79(5):689\u2013699, 2013.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9498_CR41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pathol.4.110807.092259","volume":"4","author":"SL Asa","year":"2009","unstructured":"Asa SL, Ezzat S. The pathogenesis of pituitary tumors. Annu Rev Pathol 4:97\u2013126, 2009.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"9498_CR42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/cjn.2015.301","volume":"43","author":"K Al-Dahmani","year":"2016","unstructured":"Al-Dahmani K, Mohammad S, Imran F, et al. Sellar Masses: An Epidemiological Study. Can J Neurol Sci 43(2):291\u2013297, 2016.","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"9498_CR43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0144","volume":"171","author":"A Tj\u00f6rnstrand","year":"2014","unstructured":"Tj\u00f6rnstrand A, Gunnarsson K, Evert M, et al. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. Eur J Endocrinol 171(4):519\u2013526, 2014.","journal-title":"Eur J Endocrinol"},{"key":"9498_CR44","volume-title":"Endotext [Internet]","author":"PV Carroll","year":"2016","unstructured":"Carroll PV, Jenkins PJ. Acromegaly. 2016. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth: MDText.com, Inc.; 2000- .Available from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279097\/"},{"issue":"2","key":"9498_CR45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1530\/ERC-14-0305","volume":"22","author":"I Potorac","year":"2015","unstructured":"Potorac I, Petrossians P, Daly AF, et al. Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. Endocr Relat Cancer 22(2):169\u2013177, 2015.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"9498_CR46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04286.x","volume":"77","author":"A Heck","year":"2012","unstructured":"Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, Bollerslev J. Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf). 77(1):72\u201378, 2012.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"9498_CR47","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/ERC-16-0496","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Kucharczyk W, Ezzat S. Pituitary acromegaly: not one disease. Endocr Relat Cancer 24(3):C1-C4.7, 2017.","journal-title":"Endocr Relat Cancer"},{"key":"9498_CR48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-444-59602-4.00023-X","volume":"124","author":"N Alband","year":"2014","unstructured":"Alband N, Korbonits M. Familial pituitary tumors. Handb Clin Neurol 124:339\u2013360, 2014.","journal-title":"Handb Clin Neurol"},{"issue":"9","key":"9498_CR49","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","volume":"100","author":"LC Hern\u00e1ndez-Ram\u00edrez","year":"2015","unstructured":"Hern\u00e1ndez-Ram\u00edrez LC, Gabrovska P, et al. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab 100(9):E1242\u2013E1254, 2015.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9498_CR50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/EJE-14-0426","volume":"171","author":"V Preda","year":"2014","unstructured":"Preda V, Korbonits M, Cudlip S, Karavitaki N, Grossman AB. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort. Eur J Endocrinol 171(5):659\u2013666, 2014.","journal-title":"Eur J Endocrinol"},{"issue":"25","key":"9498_CR51","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin G, Daly AF, Faucz FR, et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371(25):2363\u20132374, 2014.","journal-title":"N Engl J Med"},{"issue":"1","key":"9498_CR52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MED.0000000000000212","volume":"23","author":"MB Lodish","year":"2016","unstructured":"Lodish MB, Trivellin G, Stratakis CA. Pituitary gigantism: update on molecular biology and management. Curr Opin Endocrinol Diabetes Obes 23(1):72\u201380, 2016.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"9498_CR53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","volume":"22","author":"L Rostomyan","year":"2015","unstructured":"Rostomyan L, Daly AF, Petrossians P, et al. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 22(5):745\u2013757, 2015.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"9498_CR54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0029-1211342","volume":"103","author":"MJ Puchner","year":"1995","unstructured":"Puchner MJ, L\u00fcdecke DK, Saeger W, Riedel M, Asa SL. Gangliocytomas of the sellar region\u2014a review. Exp Clin Endocrinol Diabetes 103(3):129\u2013149, 1995.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"9498_CR55","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2013-3826","volume":"99","author":"S Salenave","year":"2014","unstructured":"Salenave S, Boyce AM, Collins MT, Chanson P. Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 99(6):1955\u20131969, 2014.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9498_CR56","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1210\/jc.2012-1274","volume":"97","author":"AO Vortmeyer","year":"2012","unstructured":"Vortmeyer AO, Gl\u00e4sker S, Mehta GU, et al. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome. J Clin Endocrinol Metab 97(7):2404\u20132413, 2012.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"9498_CR57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2013.08.022","volume":"386","author":"P Salpea","year":"2014","unstructured":"Salpea P, Stratakis CA. Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics. Mol Cell Endocrinol 386(1\u20132):85\u201391, 2014.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"9498_CR58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/ERC-11-0059","volume":"18","author":"C Villa","year":"2011","unstructured":"Villa C, Lagonigro MS, Magri F, et al. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation. Endocr Relat Cancer 18(3):347\u2013356, 2011.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"9498_CR59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","volume":"19","author":"A Obari","year":"2008","unstructured":"Obari A, Sano T, Ohyama K, et al. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19(2):82\u201391, 2008.","journal-title":"Endocr Pathol"},{"issue":"12","key":"9498_CR60","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91(12):4769\u20134775, 2006.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9498_CR61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/geronj\/35.1.16","volume":"35","author":"K Kovacs","year":"1980","unstructured":"Kovacs K, Ryan N, Horvath E, Singer W, Ezrin C. Pituitary adenomas in old age. J Gerontol 35(1):16\u201322, 1980.","journal-title":"J Gerontol"},{"issue":"1\u20132","key":"9498_CR62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386(1\u20132):2\u201315, 2014.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"9498_CR63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","volume":"168","author":"T Cuny","year":"2013","unstructured":"Cuny T, Pertuit M, Sahnoun-Fathallah M, et al. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis. Eur J Endocrinol 168(4):533\u2013541, 2013.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"9498_CR64","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","volume":"32","author":"J Trouillas","year":"2008","unstructured":"Trouillas J, Labat-Moleur F, Sturm N, et al. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol 32(4):534\u2013543, 2008.","journal-title":"Am J Surg Pathol"},{"key":"9498_CR65","doi-asserted-by":"crossref","unstructured":"Duan K, Mete O. Familial endocrine tumor syndromes: Clinical and predictive roles of molecular histopathology. AJSP Reviews and Reports, 2017. In press.","DOI":"10.1097\/PCR.0000000000000206"},{"issue":"3\u20134","key":"9498_CR66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1009958510378","volume":"1","author":"A Verloes","year":"1999","unstructured":"Verloes A, Stevenaert A, Teh BT, Petrossians P, Beckers A. Familial acromegaly: case report and review of the literature. Pituitary 1(3\u20134):273\u2013277, 1999.","journal-title":"Pituitary"},{"issue":"3","key":"9498_CR67","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-15-0038","volume":"22","author":"A Beckers","year":"2015","unstructured":"Beckers A, Lodish MB, Trivellin G, et al. X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer. 22(3):353\u2013367, 2015.","journal-title":"Endocr Relat Cancer."},{"issue":"3","key":"9498_CR68","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","volume":"100","author":"J D\u00e9nes","year":"2015","unstructured":"D\u00e9nes J, Swords F, Rattenberry E, et al. Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a largepatient cohort. J Clin Endocrinol Metab 100(3):E531\u2013E541, 2015.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"9498_CR69","first-page":"105","volume":"71","author":"AF Daly","year":"2009","unstructured":"Daly AF, Tichomirowa MA, Beckers A. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma. Horm Res.;71 Suppl 1:105\u2013111, 2009. Erratum in: Horm Res. 2009;71(5):297. Tichomirow, Maria A [corrected to Tichomirowa, Maria A].","journal-title":"Horm Res"},{"issue":"1","key":"9498_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-010-9341-5","volume":"38","author":"JS Lim","year":"2010","unstructured":"Lim JS, Ku CR, Lee MK, Kim TS, Kim SH, Lee EJ. A case of fugitive acromegaly, initially presented as invasive prolactinoma. Endocrine 38(1):1\u20135, 2010.","journal-title":"Endocrine"},{"issue":"4","key":"9498_CR71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L","volume":"47","author":"E Horvath","year":"1981","unstructured":"Horvath E, Kovacs K, Singer W, Smyth HS, Killinger DW, Erzin C, Weiss MH. Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases. Cancer 47(4):761\u2013771, 1981.","journal-title":"Cancer"},{"key":"9498_CR72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12022-009-9094-y","volume":"20","author":"EL Wang","year":"2009","unstructured":"Wang EL, Qian ZR, Yamada S et al. Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomasEndocr Pathol 20: 209\u2013220, 2009.","journal-title":"Endocr Pathol"},{"issue":"3","key":"9498_CR73","first-page":"723","volume":"47","author":"BW Scheithauer","year":"2000","unstructured":"Scheithauer BW, Jaap AJ, Horvath E, et al. Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery. 47(3):723\u2013729; discussion 729-30, 2000.","journal-title":"Neurosurgery"},{"issue":"3","key":"9498_CR74","first-page":"617","volume":"98","author":"E Horvath","year":"1980","unstructured":"Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 98(3):617\u2013638, 1980.","journal-title":"Am J Pathol"},{"issue":"2","key":"9498_CR75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","volume":"18","author":"O Cooper","year":"2015","unstructured":"Cooper O. Silent corticotroph adenomas. Pituitary 18(2):225\u2013231, 2015.","journal-title":"Pituitary"},{"issue":"3","key":"9498_CR76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12022-015-9384-5","volume":"26","author":"A Fountas","year":"2015","unstructured":"Fountas A, Giotaki Z, Ligkros N, et al. Cushing\u2019s Syndrome Due to CRH and ACTH Co-secreting Pancreatic Tumor\u2014Presentation of a New Case Focusing on Diagnostic Pitfalls. Endocr Pathol 26(3):239\u2013242, 2015.","journal-title":"Endocr Pathol"},{"issue":"5","key":"9498_CR77","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s11102-014-0595-4","volume":"18","author":"ME Domingue","year":"2015","unstructured":"Domingue ME, Marbaix E, Do Rego JL, et al. Infrasellar pituitary gangliocytoma causing Cushing's syndrome. Pituitary 18(5):738\u2013744, 2015.","journal-title":"Pituitary"},{"issue":"3","key":"9498_CR78","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAT.0b013e32835f45c5","volume":"45","author":"O Mete","year":"2013","unstructured":"Mete O, Asa SL. Precursor lesions of endocrine system neoplasms. Pathology 45(3):316\u2013330, 2013.","journal-title":"Pathology"},{"issue":"1","key":"9498_CR79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12022-012-9228-5","volume":"24","author":"C Schalin-J\u00e4ntti","year":"2013","unstructured":"Schalin-J\u00e4ntti C, Asa SL, Arola J, Sane T. Recurrent acute-onset Cushing\u2019s syndrome 6\u00a0years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH. Endocr Pathol 24(1):25\u201329, 2013.","journal-title":"Endocr Pathol"},{"issue":"8","key":"9498_CR80","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-2006-924154","volume":"114","author":"F Bayraktar","year":"2006","unstructured":"Bayraktar F, Kebapcilar L, Kocdor MA, et al. Cushing\u2019s syndrome due to ectopic CRH secretion by adrenal pheochromocytoma accompanied by renal infarction. Exp Clin Endocrinol Diabetes 114(8):444\u2013447, 2006.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"9498_CR81","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2265.1992.tb02359.x","volume":"37","author":"T O'Brien","year":"1992","unstructured":"O'Brien T, Young WF Jr, Davila DG, et al. Cushing\u2019s syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a phaeochromocytoma. Clin Endocrinol (Oxf). 37(5):460\u2013467, 1992.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"9498_CR82","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MAJ.0000000000000305","volume":"349","author":"SJ Winters","year":"2015","unstructured":"Winters SJ, Vitaz T, Nowacki MR, Craddock DC, Silverman C. Addison\u2019s Disease and Pituitary Enlargement. Am J Med Sci 349(6):526\u2013529, 2015.","journal-title":"Am J Med Sci"},{"issue":"12","key":"9498_CR83","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.clineuro.2013.09.040","volume":"115","author":"S Fan","year":"2013","unstructured":"Fan S, Jiang Y, Yao Y, Wang R, Xing B. Pituitary ACTH-secreting adenoma in Addison\u2019s disease: a case report. Clin Neurol Neurosurg 115(12):2543\u20132546, 2013.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"9498_CR84","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3171\/2014.10.FOCUS14683","volume":"38","author":"J Seltzer","year":"2015","unstructured":"Seltzer J, Ashton CE, Scotton TC, Pangal D, Carmichael JD, Zada G. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature. Neurosurg Focus 38(2):E17, 2015.","journal-title":"Neurosurg Focus"},{"issue":"4","key":"9498_CR85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1750-3639.2002.tb00458.x","volume":"12","author":"W Liu","year":"2002","unstructured":"Liu W, Asa SL, Ezzat S. Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells. Brain Pathol 12(4):412\u2013419, 2002.","journal-title":"Brain Pathol"},{"issue":"2","key":"9498_CR86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/EP:12:2:181","volume":"12","author":"K Komatsubara","year":"2001","unstructured":"Komatsubara K, Tahara S, Umeoka K, Sanno N, Teramoto A, Osamura RY. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas. Endocr Pathol 12(2):181\u2013188, 2001.","journal-title":"Endocr Pathol"},{"issue":"1","key":"9498_CR87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.onc.1201516","volume":"16","author":"PL Dahia","year":"1998","unstructured":"Dahia PL, Aguiar RC, Honegger J, et al. Mutation and expression analysis of the p27\/kip1 gene in corticotrophin-secreting tumours. Oncogene 16(1):69\u201376, 1998.","journal-title":"Oncogene"},{"issue":"1","key":"9498_CR88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A, et al. Mutations in the deubiquitinase gene USP8 cause Cushing's disease. Nat Genet 47(1):31\u201338, 2015.","journal-title":"Nat Genet"},{"issue":"7","key":"9498_CR89","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas LG, Theodoropoulou M, Ferra\u00f9 F, et al. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing\u2019s Disease. J Clin Endocrinol Metab 100(7):E997\u20131004, 2015.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9498_CR90","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH, et al. Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res 25(3):306\u2013317, 2015.","journal-title":"Cell Res"},{"issue":"2","key":"9498_CR91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","volume":"174","author":"K Hayashi","year":"2016","unstructured":"Hayashi K, Inoshita N, Kawaguchi K, et al. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease. Eur J Endocrinol 174(2):213\u2013226, 2016.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"9498_CR92","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11102-011-0363-7","volume":"15","author":"AK Annamalai","year":"2012","unstructured":"Annamalai AK, Dean AF, Kandasamy N, et al. Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature. Pituitary 15(3):276\u2013287, 2012.","journal-title":"Pituitary"},{"issue":"4","key":"9498_CR93","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12022-010-9138-3","volume":"21","author":"F Salehi","year":"2010","unstructured":"Salehi F, Scheithauer BW, Moyes VJ, et al. Low immunohistochemical expression of MGMT in ACTH secreting pituitary tumors of patients with Nelson syndrome. Endocr Pathol 21(4):227\u2013229, 2010.","journal-title":"Endocr Pathol"},{"issue":"3","key":"9498_CR94","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","volume":"61","author":"S Yamada","year":"2007","unstructured":"Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K, Sano T. A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580\u2013584; discussion 584-5, 2007.","journal-title":"Neurosurgery"},{"key":"9498_CR95","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0025-6196(11)63002-4","volume":"71","author":"WF Young","year":"1996","unstructured":"Young W F, Scheithauer B W, Kovacs K et al. Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases. Mayo Clin Proc 71: 649\u2013656, 1996.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"9498_CR96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","volume":"26","author":"JA Balogun","year":"2015","unstructured":"Balogun JA, Monsalves E, Juraschka K, et al. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol 26(1):63\u201370, 2015.","journal-title":"Endocr Pathol"},{"key":"9498_CR97","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem-66-6-1111","volume":"166","author":"E Horvath","year":"1988","unstructured":"Horvath E, Kovacs K, Smyth HS et al. A novel type of pituitary adenoma: morphological features and clinical correlations. J Clin Endocrinol Metab 166:1111\u20131118, 1988.","journal-title":"J Clin Endocrinol Metab"},{"key":"9498_CR98","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/01913120500323514","volume":"29","author":"E Horvath","year":"2005","unstructured":"Horvath E, Kovacs K, Smyth HS et al. Silent adenoma subtype 3 of the pituitary\u2014immunohistochemical and ultrastructural classification: a review of 29 cases. Ultrastruct Pathol 29:511\u2013524, 2005.","journal-title":"Ultrastruct Pathol"},{"key":"9498_CR99","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2008.03514.x","volume":"71","author":"D Erickson","year":"2009","unstructured":"Erickson D, Scheithauer B, Atkinson J et al. Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience. Clin Endocrinol (Oxf) 71:92\u201399, 2009.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"9498_CR100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12022-010-9120-0","volume":"21","author":"ME Fealey","year":"2010","unstructured":"Fealey ME, Scheithauer BW, Horvath E, Erickson D, Kovacs K, McLendon R, Lloyd RV. MGMT immunoexpression in silent subtype 3 pituitary adenomas: possible therapeutic implications. Endocr Pathol 21(3):161\u2013165, 2010.","journal-title":"Endocr Pathol"},{"issue":"4","key":"9498_CR101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","volume":"13","author":"RA Toledo","year":"2017","unstructured":"NGS in PPGL (NGSnPPGL) Study Group, Toledo RA, Burnichon N, et al. Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 13(4):233\u2013247, 2017.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"9498_CR102","first-page":"871","volume":"124","author":"K Duan","year":"2016","unstructured":"Duan K, Mete O. Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers. Cancer 124(12):871\u2013884, 2016.","journal-title":"Cancer"},{"issue":"8","key":"9498_CR103","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.mpdhp.2014.06.002","volume":"20","author":"T Hayashi","year":"2014","unstructured":"Hayashi T, Mete O. Head and Neck Paragangliomas: What does the pathologist need to know? Diagn Histopathol 20(8):316\u2013325, 2014.","journal-title":"Diagn Histopathol"},{"issue":"11","key":"9498_CR104","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3174\/ajnr.A2717","volume":"32","author":"MF Covington","year":"2011","unstructured":"Covington MF, Chin SS, Osborn AG. Pituicytoma, spindle cell oncocytoma, and granular cell tumor: clarification and meta-analysis of the world literature since 1893. AJNR Am J Neuroradiol 32(11):2067\u20132072, 2011.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"9498_CR105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/NEN.0b013e3181a13fca","volume":"68","author":"EB Lee","year":"2009","unstructured":"Lee EB, Tihan T, Scheithauer BW, Zhang PJ, Gonatas NK. Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker? J Neuropathol Exp Neurol 68(5):482\u2013488, 2009.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"9498_CR106","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/PAS.0b013e31829723e7","volume":"37","author":"O Mete","year":"2013","unstructured":"Mete O, Lopes MB, Asa SL. Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 37(11):1694\u20131699, 2013.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"9498_CR107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00234685","volume":"205","author":"Y Takei","year":"1980","unstructured":"Takei Y, Seyama S, Pearl GS, Tindall GT. Ultrastructural study of the human neurohypophysis. II. Cellular elements of neural parenchyma, the pituicytes. Cell Tissue Res 205(2):273\u2013287, 1980.","journal-title":"Cell Tissue Res"},{"issue":"4","key":"9498_CR108","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s12022-013-9279-2","volume":"25","author":"Z Saeed Kamil","year":"2014","unstructured":"Saeed Kamil Z, Sinson G, Gucer H, Asa SL, Mete O. TTF-1 expressing sellar neoplasm with ependymal rosettes and oncocytic change: mixed ependymal and oncocytic variant pituicytoma. Endocr Pathol 25(4):436\u2013438, 2014.","journal-title":"Endocr Pathol"},{"issue":"2","key":"9498_CR109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","volume":"87","author":"B Verg\u00e8s","year":"2002","unstructured":"Verg\u00e8s B, Boureille F, Goudet P, et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 87(2):457\u2013465, 2002.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9498_CR110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-0004.2010.01406.x","volume":"78","author":"CA Stratakis","year":"2010","unstructured":"Stratakis CA, Tichomirowa MA, Boikos S, et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 78(5):457\u2013463, 2010.","journal-title":"Clin Genet"},{"issue":"6","key":"9498_CR111","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1530\/ERC-12-0118","volume":"19","author":"P Xekouki","year":"2012","unstructured":"Xekouki P, Stratakis CA. Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and\/or Krebs cycle defects? Endocr Relat Cancer 19(6):C33\u2013C40, 2012.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"9498_CR112","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1750-3639.2001.tb00403.x","volume":"11","author":"R Yu","year":"2001","unstructured":"Yu R, Melmed S. Oncogene activation in pituitary tumors. Brain Pathol 11(3):328\u2013341, 2001.","journal-title":"Brain Pathol"},{"issue":"3","key":"9498_CR113","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1010655419332","volume":"52","author":"A Suhardja","year":"2001","unstructured":"Suhardja A, Kovacs K, Rutka J. Genetic basis of pituitary adenoma invasiveness: a review. J Neuro-Oncol 52(3):195\u2013204, 2001.","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"9498_CR114","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12022-007-9006-y","volume":"18","author":"Y Tanizaki","year":"2007","unstructured":"Tanizaki Y, Jin L, Scheithauer BW, Kovacs K, Roncaroli F, Lloyd RV. P53 gene mutations in pituitary carcinomas. Endocr Pathol 18(4):217\u2013222, 2007.","journal-title":"Endocr Pathol"},{"issue":"6","key":"9498_CR115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2265.1994.tb02797.x","volume":"41","author":"A Levy","year":"1994","unstructured":"Levy A, Hall L, Yeudall WA, Lightman SL. p53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol (Oxf). 41(6):809\u2013814, 1994.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6236","key":"9498_CR116","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","volume":"340","author":"CA Landis","year":"1989","unstructured":"Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340(6236):692\u2013696, 1989.","journal-title":"Nature"},{"key":"9498_CR117","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/153537020322800904","volume":"228","author":"A Lania","year":"2003","unstructured":"Lania A, Mantovani G, Spada A. Genetics of pituitary tumors: focus on G-protein mutations. Exp Biol Med 228: 1004\u20131017, 2003.","journal-title":"Exp Biol Med"},{"issue":"1","key":"9498_CR118","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","volume":"4","author":"D Iacovazzo","year":"2016","unstructured":"Iacovazzo D, Caswell R, Bunce B, et al. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study. Acta Neuropathol Commun 4(1):56, 2016.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-017-9498-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-017-9498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-017-9498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T18:21:52Z","timestamp":1719339712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-017-9498-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["9498"],"URL":"https:\/\/doi.org\/10.1007\/s12022-017-9498-z","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}